Document 0507
 DOCN  M9590507
 TI    Headache and the human immunodeficiency virus type 1 infection.
 DT    9509
 AU    Holloway RG; Kieburtz KD; University of Rochester (NY) School of
       Medicine and Dentistry,; USA.
 SO    Headache. 1995 May;35(5):245-55. Unique Identifier : AIDSLINE
       MED/95293668
 AB    This review focuses on the prevalence, causes, evaluation, and treatment
       of headache in individuals infected with human immunodeficiency virus
       type 1 (HIV-1). Headaches, one of the commonest medical complaints in
       the general population, occur frequently in patients infected with the
       HIV-1. HIV-related headaches can occur at any time during the infection:
       at seroconversion, during the incubation period, in patients with
       symptomatic HIV-1 infection, or after an AIDS-defining illness. Causes
       of HIV-related headaches include HIV-1 itself, opportunistic conditions,
       or HIV-specific medications. Migraines, tension-type headaches,
       depression, and substance abuse enter into the differential diagnosis,
       particularly in the early stages of disease. The headaches seen in this
       population reflect a complex web of interactions imposed by immune
       competency, multiple etiologies, treatments, and premorbid conditions.
       Prompt recognition and early treatment of headache is essential since it
       may improve quality of life and, depending on the diagnosis, prolong
       survival. Physicians need to be alert and adaptable when assessing
       HIV-infected individuals with headache since multiple causes can exist
       in the same patient and new syndromes, complications, and
       investigational drugs are continually being identified.
 DE    Acquired Immunodeficiency Syndrome/*COMPLICATIONS/DRUG THERAPY
       Diagnosis, Differential  Drug Interactions
       Headache/*COMPLICATIONS/DIAGNOSIS/DRUG THERAPY  Human  *HIV-1  Prognosis
       JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).